Skip to main content
Erschienen in: Indian Journal of Pediatrics 5/2016

26.02.2016 | Original Article

Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study

verfasst von: J. Kurian, J. Mathew, K. Sowjanya, K. R. K. Chaitanya, M. Ramesh, J. Sebastian, D. Narayanappa

Erschienen in: Indian Journal of Pediatrics | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To determine the incidence, pattern, causality, preventability, severity and predictors of adverse drug reactions (ADRs) in pediatric population.

Methods

It was a prospective, observational study that included patients of either sex, of any age treated in the pediatric wards of a tertiary care hospital. Study patients were followed throughout their hospital stay. Whenever an ADR was detected, all the required data was collected and analyzed. Data was analyzed for incidence, causality (by using WHO Probability scale and Naranjo’s algorithm), preventability (by using Modified Shumock and Thornton scale), severity (by using Modified Hartwig and Siegel scale) and predictors of ADRs.

Results

Of the 1775 children admitted in the pediatrics ward, 1082 patients met study criteria and were enrolled into the study. A total of 64 ADRs were identified from 54 patients. The incidence of ADRs was 4.99 %. Male patients experienced majority (68.52 %) of ADRs. Drugs most commonly implicated in ADRs were amoxicillin + clavulanate (21.87 %) followed by ceftriaxone (20.31 %). Most (51.56 %) of the ADRs reported belonged to the system organ class, gastrointestinal system disorders. Among the ADRs reported, 82.85 % of ADRs were mild. Majority (87.5 %) of the ADRs were of ‘probable’ causality category and 96.9 % were not preventable. There was a significant association between occurrence of ADRs and the use of ≥4 number of medications, age (infants) and gender (male).

Conclusions

Among the pediatric population, infants, male gender and those receiving ≥4 number of medications are at risk of developing ADRs. Constant monitoring is required to address the safety issue in pediatric population especially in infants and patients receiving ≥4 drugs.
Literatur
1.
Zurück zum Zitat Priyadharshini R, Surendiran A, Adithan C, Sreenivasan S, Sahoo FK. A study of adverse drug reactions in paediatrics patients. J Pharmacol Pharmacother. 2011;2:277–80. Priyadharshini R, Surendiran A, Adithan C, Sreenivasan S, Sahoo FK. A study of adverse drug reactions in paediatrics patients. J Pharmacol Pharmacother. 2011;2:277–80.
2.
Zurück zum Zitat Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonat M. Incidence of adverse drug reactions in paediatric in/out patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52:77–83.CrossRefPubMedPubMedCentral Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonat M. Incidence of adverse drug reactions in paediatric in/out patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52:77–83.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Khan LM, Al-Harthi SE, Saadah OI. Adverse drug reactions in hospitalized paediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR. Saudi Pharm J. 2013;21:261–6.CrossRefPubMedPubMedCentral Khan LM, Al-Harthi SE, Saadah OI. Adverse drug reactions in hospitalized paediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR. Saudi Pharm J. 2013;21:261–6.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Kumar S, Baldi A. Pharmacovigilance in India: perspectives and prospects. J Drug Deliv Therap. 2013;3:237–47. Kumar S, Baldi A. Pharmacovigilance in India: perspectives and prospects. J Drug Deliv Therap. 2013;3:237–47.
9.
Zurück zum Zitat Berry MA, Shah PS, Brouillette RT, Hellmann J. Predictors of mortality and length of stay for neonates admitted to children’s hospital neonatal intensive care units. J Perinatol. 2008;28:297–302.CrossRefPubMed Berry MA, Shah PS, Brouillette RT, Hellmann J. Predictors of mortality and length of stay for neonates admitted to children’s hospital neonatal intensive care units. J Perinatol. 2008;28:297–302.CrossRefPubMed
10.
Zurück zum Zitat Neubert A, Dormann H, Weiss J, et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf. 2004;27:1059–67.CrossRefPubMed Neubert A, Dormann H, Weiss J, et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf. 2004;27:1059–67.CrossRefPubMed
11.
Zurück zum Zitat Smyth RMD, Gargon E, Kirkham J, et al. Adverse drug reactions in children-a systematic review. PLoS One. 2012;7:1–24. Smyth RMD, Gargon E, Kirkham J, et al. Adverse drug reactions in children-a systematic review. PLoS One. 2012;7:1–24.
12.
Zurück zum Zitat Jose J, Rao PGM. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res. 2006;54:226–33.CrossRefPubMed Jose J, Rao PGM. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res. 2006;54:226–33.CrossRefPubMed
13.
Zurück zum Zitat Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1156–64.CrossRef Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1156–64.CrossRef
14.
Zurück zum Zitat Thiesen S, Elizabeth JC, Bellis JR, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children – a prospective observational cohort study of 6,601 admissions. BMC Med. 2013;11:237–47.CrossRefPubMedPubMedCentral Thiesen S, Elizabeth JC, Bellis JR, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children – a prospective observational cohort study of 6,601 admissions. BMC Med. 2013;11:237–47.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Bellis R, Kirkham JJ, Thiesen S, et al. Adverse drug reactions and off-label and unlicensed medicines in children: a nested case–control study of inpatients in a pediatric hospital. BMC Med. 2013;11:238–46.CrossRefPubMedPubMedCentral Bellis R, Kirkham JJ, Thiesen S, et al. Adverse drug reactions and off-label and unlicensed medicines in children: a nested case–control study of inpatients in a pediatric hospital. BMC Med. 2013;11:238–46.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Gallagher M, Mason JR, Bird KA, et al. Adverse drug reactions causing admission to a paediatric hospital. PLoS One. 2012;7:1–8.CrossRef Gallagher M, Mason JR, Bird KA, et al. Adverse drug reactions causing admission to a paediatric hospital. PLoS One. 2012;7:1–8.CrossRef
17.
Zurück zum Zitat Oshikoya KA, Chukwura H, Njokanma OF, Senbanjo IO, Ojo I. Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria. Sao Paulo Med J. 2011;129:153–64.CrossRefPubMed Oshikoya KA, Chukwura H, Njokanma OF, Senbanjo IO, Ojo I. Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria. Sao Paulo Med J. 2011;129:153–64.CrossRefPubMed
18.
Zurück zum Zitat Posthumus AAG, Carien CWA, Zwaan CCM, et al. Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study. BMJ Open. 2012;2:1–7.CrossRef Posthumus AAG, Carien CWA, Zwaan CCM, et al. Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study. BMJ Open. 2012;2:1–7.CrossRef
19.
Zurück zum Zitat Clarkson A, Conroy S, Burroughs K, Choonara I. Surveillance for adverse drug reactions in children: a paediatric regional monitoring centre. Paediatr Perinatal Drug Ther. 2004;6:20–3.CrossRef Clarkson A, Conroy S, Burroughs K, Choonara I. Surveillance for adverse drug reactions in children: a paediatric regional monitoring centre. Paediatr Perinatal Drug Ther. 2004;6:20–3.CrossRef
Metadaten
Titel
Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study
verfasst von
J. Kurian
J. Mathew
K. Sowjanya
K. R. K. Chaitanya
M. Ramesh
J. Sebastian
D. Narayanappa
Publikationsdatum
26.02.2016
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 5/2016
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-015-2002-1

Weitere Artikel der Ausgabe 5/2016

Indian Journal of Pediatrics 5/2016 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.